News

Public · Published

Expansion of collaboration with IBM: Aqarios software now available directly through IBM

Aqarios Quantum Technologies says its subsidiary Aqarios GmbH signed a further agreement with IBM. IBM will offer Aqarios' Constrained Quantum Optimizer software directly on the IBM Quantum Platform, bill customers itself, and pay Aqarios a license fee for every software call. The arrangement follows the software's September 2026 catalog inclusion.

Published:

Updated:

What happened

Aqarios Quantum Technologies says its subsidiary Aqarios GmbH signed a further agreement with IBM. IBM will offer Aqarios’ Constrained Quantum Optimizer software directly on the IBM Quantum Platform, bill customers itself, and pay Aqarios a license fee for every software call. The arrangement follows the software’s September 2026 catalog inclusion.

Confirmed

Global impact / market context

Selling through IBM lets customers use the software under their existing IBM contracts, without a separate purchase from Aqarios. The per-call license fee links Aqarios’ revenue from this channel to software use, while IBM handles customer billing, potentially easing sales access but not guaranteeing demand.

Analyst inference

The announcement describes a distribution and payment arrangement, not reported sales, earnings, or customer usage. Its financial effect therefore depends on how often IBM customers call the software and the resulting license fees; the article provides no usage figures or revenue forecast.

Analyst inference

What to watch

  1. Whether IBM Quantum Platform customers begin using the optimizer, and whether Aqarios or IBM later reports call volumes that clarify the scale of this usage-based revenue channel. Analyst inference
  2. Whether the agreement produces additional IBM catalog offerings or other commercial arrangements; the announcement confirms this is a further agreement but gives no broader rollout plans. Analyst inference
  3. Any reported license revenue or usage figures from Aqarios, which would show whether the per-call payment structure is translating into meaningful sales rather than availability alone. Analyst inference

Evidence